© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Chemical Name: Epidermal Growth Factor, Human
Common Names: EGF, Recombinant Human Epidermal Growth Factor
Molecular Weight: Around 6.2 kDa for the mature protein
Chemical Formula: C257H381N73O83S7 (based on amino acid sequence)
Intended Use: Primarily for laboratory research, specifically cell culture applications and biotechnology research into skin regeneration and wound healing
Description: Lab workers typically encounter the recombinant version expressed in E. coli or yeast, and there's real focus on maintaining purity for experimental reliability
Storage Recommendations: Usually shipped freeze-dried under low humidity, researchers understand the value of keeping vials at -20°C or below and always away from light and moisture
Hazard Classification: No official GHS classification for EGF itself; not flagged for acute toxicity, carcinogenicity, or environmental harm under most regulations
Routes of Exposure: Laboratory exposure comes mainly through skin or eye contact, inhalation of powder, or accidental injection
Health Risks: Current research and lab safety notes suggest low acute risk, but protein solutions can sometimes cause allergy-like symptoms if staff are repeatedly exposed
Symptoms of Exposure: Eye or skin irritation, possible local inflammation, in rare cases mild hypersensitivity
Precautionary Approach: Laboratory safety should still go beyond risk labels, as unpredictability remains with biologically active compounds
Main Component: Recombinant human EGF (amino acid sequence matched to endogenous human protein)
Purity: Normally marketed above 95%, and typically free from animal-derived material to minimize allergy risks
Other Ingredients: Trace buffer salts and sugars, such as mannitol or trehalose, sometimes included for freeze-drying stability; no known hazardous excipients at research grade
Impurities: Reputable sources provide confirmation that endotoxin, host cell proteins, and DNA are tested and kept below harmful thresholds
Eye Contact: Rinse immediately with a steady stream of water, especially for protein powder exposure
Skin Contact: Wash with soap and water, carefully removing contaminated clothing
Inhalation: Move to fresh air, monitor for respiratory irritation, and seek medical advice if symptoms persist
Ingestion: Rinse mouth with water, though accidental ingestion is rare and not anticipated to cause serious harm at quantities used in research
Follow-up: Medical personnel ought to know the compound is a human peptide, and risk of severe toxicity is recognized as minimal, but allergy can surprise even experienced lab staff
Flammability: Protein materials like EGF powder carry negligible fire risk in solution, but dry bulk can combust under direct flame
Suitable Extinguishing Media: Use water spray, carbon dioxide, dry chemical, or foam for packaging or adjacent fire
Special Hazards: Combustion yields carbon oxides, nitrogen oxides, sulfur oxides; no unique toxic byproducts noted compared to other proteins
Protective Equipment: Firefighters handling research labs still benefit from standard self-contained breathing apparatus
Explosion Risk: No known explosive properties under research lab handling and storage practices
Personal Precautions: Laboratory coats, gloves, and eye protection prevent irritation and direct contact
Environmental Measures: Small spills absorbed with paper towel or lab tissue, then cleaned with alcohol or detergent solutions
Cleanup Methods: Wet clean to control dust for powder, ventilate area, discard waste following local biosafety procedure
Secondary Risk: Carried dust does not pose significant airborne hazard, but regular cleaning helps maintain a safe working space
Handling: Only open vials in well-ventilated areas, avoid inhalation, and take care with powder transfer
Unsafe Practices: Eating, drinking, and unsupervised pipetting heighten personal risk
Storage: Maintain at required -20°C or -80°C for long-term preservation, keeping the vial sealed until use to protect from oxidation or degradation
Equipment Care: Rigor in pipette maintenance and workspace sterilization goes far in avoiding cross-contamination
Engineering Controls: Standard lab practice involves biosafety cabinets for powder manipulation
Personal Protective Equipment: Gloves, splash-proof eyewear, lab coat
Hygiene Measures: Handwashing post-use, regular surface disinfection
Occupational Exposure Limit: Authorities set no official limits for EGF, but universal laboratory PPE remains necessary
Appearance: White to off-white lyophilized powder, clear to slightly cloudy solution once rehydrated
Odor: Odorless
Solubility: Freely soluble in water, best dissolved in sterile buffers
pH Range: Solutions are generally neutral to slightly acidic, around pH 6–7
Stability: Light and heat sensitive, rapidly inactivates outside optimal storage; proper handling keeps it from losing potency
Chemical Stability: Stable at recommended storage temperatures; quickly degrades at room temperature
Reactivity: Does not react with standard lab plastics or glass; potential sensitivity to extreme pH shifts or oxidative chemicals
Hazardous Decomposition: On strong heating, typical protein combustion products such as CO2, CO, sulfur oxides form
Incompatibilities: Strong acids, bases, oxidizers disrupt protein structure and activity
Acute Toxicity: No evidence for acute toxic effects at lab exposure levels
Dermal and Ocular Impact: Temporary, localized irritation in rare cases
Chronic Effects: No data showing chronic toxicity for EGF, but as with any biologically active molecule, researchers limit long-term or repeated exposure
Sensitization: Possible hypersensitivity reactions with repeated or prolonged direct contact, especially powder forms
Carcinogenicity: Not classified as carcinogenic by leading regulatory bodies, though its function in cell proliferation demands good lab controls to limit unnecessary exposure
Acute Environmental Impact: No direct data shows harm to aquatic or terrestrial environments at laboratory spill scales
Degradability: Protein readily breaks down in wastewater systems, undergoes enzymatic and microbial digestion
Bioaccumulation Risk: EGF does not bioaccumulate, as it degrades rapidly in the environment
Best Practice: Avoid disposal into surface water or soil, as with any concentrated lab material, out of precaution
Lab Waste Disposal: EGF solutions and powders treated according to standard biological waste guidelines
Down-the-Drain Disposal: Local regulation often permits diluted protein waste down the drain, but verification with institutional policy is vital
Solid Waste: Contaminated materials bagged and autoclaved or incinerated, not added to general trash
Emphasis: Careful disposal supports institutional duty to health and safety as well as environmental responsibility
International Shipping: Not classified as a hazardous material by air, sea, or road transport under UN standards
Packaging: Ship refrigerated or with dry ice for stability during transit
Special Precautions: Use leak-proof containers, secondary containment to avoid accidental release
Regulatory Status: Registered under general protein product categories, exempt from high-level biohazard controls by most authorities
Legal Status: Permitted for research and industrial use under normal laboratory controls
Labelling: Protein product labels remind users of peptide nature and best laboratory practice requirements
Workplace Regulation: Not subject to workplace exposure limits or chemical-specific restrictions in most countries
Worker Training: Proper lab induction, respirator fit testing, and biohazard training recommended for any staff handling dry or lyophilized peptide vials
Additional Responsibility: Persistence in educating research staff on new findings and hazard updates keeps lab and environment safer in the long run
